| Name: |
|
| Other Names: |
|
|
Classification:
|
- Dissociative anesthetic with profound analgesic and moderate hypnotic properties
|
|
Mechanism of Action:
|
- N-methyl-D-aspartate (NMDA) – receptor antagonist
- Sympathomimetic properties, inhibition of central/peripheral cholinergic transmission with effects on opiate receptors
- Onset intravenous/intraosseous 1-2 minutes with a duration of 5-10 minutes; intranasal 5-10 minutes with a duration up to 60 minutes
|
|
Indications:
|
- Induction and maintenance of general anesthesia
- Analgesia and sedation
- Rapid Sequence Sedation/Drug assisted intubation
|
|
Contraindications:
|
- Hypersensitivity
- Increased ICP
- Seizure disorders
- Uncontrolled HTN
|
|
Adverse Effects:
|
- Increased oral secretions
- Tachy/brady arrhythmias
- Increased ICP
- Mild cardiac depression
- Nystagmus
- Transient laryngospasm
- Hallucinations
|
|
Dose:
|
|
| Adult: |
- Analgesia
- 0.15 mg/kg IV/IO/IN; may be repeated every 5-10 minutes to a maximum of 2 doses
- Preference is IV/IO first; if unable to obtain access, can then be given IN
- Procedural sedation (non-intubated):
- Initial: 0.5-1 mg/kg IV/IO over 2 minutes
- Repeat boluses: 0.25 – 0.5 mg/kg IV/IO; can be repeated every 15 minutes to a maximum of 2 doses
- Drug Assisted Intubation:
- 2 mg/kg IV/IO
- 1 mg/kg IV/IO for patients in shock
- Post-intubation Sedation (Advanced Airway):
- 0.5 mg/kg IV/IO
- 0.5 mg/kg/hr OR 8 mcg/kg/min IV/IO (200 mg in 100 mL of solution) infusion to a maximum infusion rate of 1.8 mg/kg/hr OR 30 mcg/kg/min
- Chemical Restraint
- Agitation dosage:
- 0.5 mg – 1.0 mg/kg IV/IO single dose after midazolam has been maxed
- Excited Delirium dosages:
- 4 mg/kg IM (max dosage 4 mg/kg)
|
| Pediatric: |
- Same as adult dosage (infusion dosage 8 mcg/kg/min – 30 mcg/kg/min)
- Post- intubation sedation for an advanced airway is for patients greater than 5 kg
|
| Routes: |
|
| Special Notes: |
- Compatible with D5W or NS
- Compatible at Y site with (partial list): Propofol, Fentanyl, Midazolam, Morphine, Lidocaine, Hydromorphone)
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Professional 2nd Edition
|
Last modified: Wednesday, 26 March 2025, 1:33 PM